{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:10Z","timestamp":1761058930294},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/bf03021611","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T20:18:54Z","timestamp":1241381934000},"page":"1093-1098","source":"Crossref","is-referenced-by-count":17,"title":["Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia","\u013danticoagulation avec la bivalirudine pour la circulation extracorporelle chez un patient atteint de thrombocytop\u00e9nie immunitaire \u00e0 \u013eh\u00e9parine (TIH)"],"prefix":"10.1007","volume":"52","author":[{"given":"Marcin","family":"Wasowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Vegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Borger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03021611_CR1","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","volume":"126","author":"TE Warkentin","year":"2004","unstructured":"Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh AACP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 311S-37S.","journal-title":"Chest"},{"key":"BF03021611_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejcts.2004.09.021","volume":"27","author":"AT Gurbuz","year":"2005","unstructured":"Gurbuz AT, Elliot WG, Zia AA. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. Eur J Cardiothorac Surg 2005; 27: 138\u201349.","journal-title":"Eur J Cardiothorac Surg"},{"key":"BF03021611_CR3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1345\/aph.1A197","volume":"36","author":"TM Sciulli","year":"2002","unstructured":"Sciulli TM, Mauro VF. Pharmacology and clinical use of bivalirudin. Ann Pharmacother 2002; 36: 1028\u201341.","journal-title":"Ann Pharmacother"},{"key":"BF03021611_CR4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(02)04299-6","volume":"75","author":"Z Davis","year":"2003","unstructured":"Davis Z, Anderson R, Short D, Garber D, Valgiusti A. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Ann Thorac Surg 2003; 75: 264\u20135.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0003-4975(03)00144-9","volume":"76","author":"JN Bott","year":"2003","unstructured":"Bott JN, Reddy K, Krick S. Bivalrudin use in off-pump myocardial revascularization in patients with heparininduced thrombocytopenia. Ann Thorac Surg 2003; 76: 273\u20135.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjcard.2003.10.021","volume":"93","author":"A Koster","year":"2004","unstructured":"Koster A, Spiess B, Chew DP, et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004; 93: 356\u20139.","journal-title":"Am J Cardiol"},{"key":"BF03021611_CR7","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1378\/chest.127.2_suppl.46S","volume":"127","author":"WH Matthai","year":"2005","unstructured":"Matthai WH jrJr. Thrombocytopenia in cardiovascular patients. Diagnosis and management. Chest 2005; 127: 46S-52S.","journal-title":"Chest"},{"key":"BF03021611_CR8","first-page":"487","volume-title":"New Anticoagulants for the Cardiovascular Patient","author":"HN Magnani","year":"1997","unstructured":"Magnani HN, Beijering RJ, Ten Cate JW, Chong BH. Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.In: Pifarre R (Ed.). New Anticoagulants for the Cardiovascular Patient. Philadelphia: Hanley & Belfus Inc.; 1997: 487\u2013500."},{"key":"BF03021611_CR9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00000542-198912000-00010","volume":"71","author":"VJ Zulys","year":"1989","unstructured":"Zulys VJ, Teasdale SJ, Michel ER, et al. Ancrod (Arvin\u00ae) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 1989; 71: 870\u20137.","journal-title":"Anesthesiology"},{"key":"BF03021611_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/cr.2000.5861","volume":"14","author":"A Koster","year":"2000","unstructured":"Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 2000; 14: 243\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"BF03021611_CR11","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0003-4975(02)04782-3","volume":"75","author":"JT Edwards","year":"2003","unstructured":"Edwards JT, Hamby JK, Worrall NK. Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 2003; 75: 1622\u20134.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1213\/00000539-200302000-00009","volume":"96","author":"GA Nuttall","year":"2003","unstructured":"Nuttall GA, Oliver WC jrJr,Santrach PJ, et al. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Anesth Analg 2003; 96: 344\u201350.","journal-title":"Anesth Analg"},{"key":"BF03021611_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000542-200402000-00038","volume":"100","author":"S Malherbe","year":"2004","unstructured":"Malherbe S, Tsui BC, Stobart K, Koller J. Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anesthesiology 2004; 100: 443\u20135.","journal-title":"Anesthesiology"},{"key":"BF03021611_CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.athoracsur.2003.04.001","volume":"77","author":"MA Cannon","year":"2004","unstructured":"Cannon MA, Butterworth J, Riley RD, Hyland JM. Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 711\u20133.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0003-4975(03)01471-1","volume":"78","author":"SB Clayton","year":"2004","unstructured":"Clayton SB, Acsell JR, Crumbley III AJ, Shackelford AG, Uber WE. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Ann Thorac Surg 2004; 78: 2167\u20139.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1213\/01.ANE.0000114072.71353.D5","volume":"98","author":"G Stratmann","year":"2004","unstructured":"Stratmann G, deSilva AM, Tseng EE, et al. Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. Anesth Analg 2004; 98: 1635\u20139.","journal-title":"Anesth Analg"},{"key":"BF03021611_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/00000542-200410000-00056","volume":"101","author":"IJ Welsby","year":"2004","unstructured":"Welsby IJ, Stafford-Smith M. Monitoring direct thrombin inhibitors: time for standardization (Letter). Anesthesiology 2004; 101: 1048\u20139.","journal-title":"Anesthesiology"},{"key":"BF03021611_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH03-09-0571","volume":"91","author":"AF Klenner","year":"2004","unstructured":"Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004; 91: 719\u201324.","journal-title":"Thromb Haemost"},{"key":"BF03021611_CR19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.athoracsur.2003.09.061","volume":"77","author":"AF Merry","year":"2004","unstructured":"Merry AF, Raudkivi PJ, Middleton NG, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 925\u201331.","journal-title":"Ann Thorac Surg"},{"key":"BF03021611_CR20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1213\/00000539-200302000-00015","volume":"96","author":"A Koster","year":"2003","unstructured":"Koster A, Chew D, Grundel M, Bauer M, Kuppe H, Spiess BD. Bivalirudin monitored with ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg 2003; 96: 383\u20136.","journal-title":"Anesth Analg"},{"key":"BF03021611_CR21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000081506","volume":"33","author":"U Lange","year":"2003","unstructured":"Lange U, Nowak G, Bucha E. Ecarin chromogenic assay \u2014 a new method for quantitative determination of direct thrombin inhibitors like hirudin. Pathophysiol Haemost Thromb 2003; 33: 184\u201391.","journal-title":"Pathophysiol Haemost Thromb"},{"key":"BF03021611_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200207000-00004","volume":"95","author":"A Koster","year":"2002","unstructured":"Koster A, Despotis G, Gruendel M, et al. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Anesth Analg 2002; 95: 26\u201330.","journal-title":"Anesth Analg"},{"key":"BF03021611_CR23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1051\/ject\/2004362174","volume":"36","author":"K Jabr","year":"2004","unstructured":"Jabr K, Johnson JH, McDonald MH, et al. Plasma modified ACT can be used to monitor bivalirudin (Angiomax\u00ae) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparininduced thrombocytopenia. J Extra Corpor Technol 2004; 36: 174\u20137.","journal-title":"J Extra Corpor Technol"},{"key":"BF03021611_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000539-200107000-00007","volume":"93","author":"GJ Despotis","year":"2001","unstructured":"Despotis GJ, Hogue CW, Saleem R, et al. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. Anesth Analg 2001; 93: 28\u201332.","journal-title":"Anesth Analg"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03021611.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03021611\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03021611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:07:53Z","timestamp":1710299273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03021611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF03021611"],"URL":"https:\/\/doi.org\/10.1007\/bf03021611","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}